Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$164.32 - $212.72 $129 Million - $167 Million
-783,726 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$130.46 - $172.63 $102 Million - $135 Million
783,726 New
783,726 $132 Million
Q3 2020

Nov 12, 2020

SELL
$146.22 - $169.13 $6,579 - $7,610
-45 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $6,138 - $7,388
45 New
45 $8,000
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $50,466 - $62,506
-472 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $34,617 - $40,747
311 Added 193.17%
472 $62,000
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $17,049 - $19,101
161 New
161 $19,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $743B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Brandywine Global Investment Management, LLC Portfolio

Follow Brandywine Global Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.